A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level
Clinical trial NCT03427710 · COMPLETED
Trial details
- NCT number
- NCT03427710
- Sponsor
- Civi Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2020-02-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.